Association between implantable cardioverter-defibrillator and survival in patients awaiting heart transplantation: A meta-analysis and systematic review
Background: Patients with end-stage heart failure are at high risk for sudden cardiac death. However, implantable cardioverter-defibrillator (ICD) is not routinely implanted given the high competing risk of pump failure. A unique population worth separate consideration are patients with end-stage he...
Main Authors: | Andrew Y. Lin, MD, Jason M. Duran, MD, PhD, Alexandra Sykes, MD, Douglas Darden, MD, Marcus Urey, MD, Jonathan C. Hsu, MD, MAS, FHRS, Eric D. Adler, MD, Ulrika Birgersdotter-Green, MD, FHRS |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-12-01
|
Series: | Heart Rhythm O2 |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666501821001951 |
Similar Items
-
The runaway defibrillator…A case of an implantable cardioverter-defibrillator that failed communication and deactivation with a magnet
by: Mahmoud Assaad, MD, et al.
Published: (2016-01-01) -
Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)Key Findings
by: Mehmet K. Aktas, MD, MBA, FHRS, et al.
Published: (2020-06-01) -
The wearable cardioverter-defibrillator is not needed for most high-risk patients
by: Advay G. Bhatt, MD, FHRS, et al.
Published: (2020-08-01) -
The wearable cardioverter-defibrillator is needed for most high-risk patients
by: Byron K. Lee, MD, MAS
Published: (2020-08-01) -
Subcutaneous implantable cardioverter defibrillator in complex adult congenital heart disease. Results from the S-ICD “Monaldi Care” registry
by: Berardo Sarubbi, et al.
Published: (2021-05-01)